Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunoglobulin M Paraproteinaemias.
Girard LP, Soekojo CY, Ooi M, Poon LM, Chng WJ, de Mel S. Girard LP, et al. Among authors: de mel s. Cancers (Basel). 2020 Jun 25;12(6):1688. doi: 10.3390/cancers12061688. Cancers (Basel). 2020. PMID: 32630470 Free PMC article. Review.
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.
Chang EWY, Yang VS, Ong SY, Kang HX, Lim BY, de Mel S, Ng EKY, Poon ML, Tan YH, Chiang J, Poon E, Somasundaram N, Farid M, Tang T, Tao M, Khoo LP, Cheng CL, Huang D, Ong CK, Lim ST, Chan JY. Chang EWY, et al. Among authors: de mel s. Leuk Lymphoma. 2023 Nov-Dec;64(11):1782-1791. doi: 10.1080/10428194.2023.2235043. Epub 2023 Jul 21. Leuk Lymphoma. 2023. PMID: 37477443
Implications of heterogeneity in multiple myeloma.
de Mel S, Lim SH, Tung ML, Chng WJ. de Mel S, et al. Biomed Res Int. 2014;2014:232546. doi: 10.1155/2014/232546. Epub 2014 Jul 2. Biomed Res Int. 2014. PMID: 25101266 Free PMC article. Review.
Risk Stratification in Multiple Myeloma.
Ooi MG, de Mel S, Chng WJ. Ooi MG, et al. Among authors: de mel s. Curr Hematol Malig Rep. 2016 Apr;11(2):137-47. doi: 10.1007/s11899-016-0307-4. Curr Hematol Malig Rep. 2016. PMID: 26883334 Review.
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group.
Ong SY, de Mel S, Chen YX, Ooi MG, Surendran S, Lin A, Koh LP, Linn YC, Ho AY, Hwang WY, Phipps C, Loh SM, Goh YT, Tan D, Chng WJ, Gopalakrishnan SK. Ong SY, et al. Among authors: de mel s. Bone Marrow Transplant. 2016 Jul;51(7):933-7. doi: 10.1038/bmt.2016.43. Epub 2016 Mar 14. Bone Marrow Transplant. 2016. PMID: 26974274
Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myeloma.
de Mel S, Chen Y, Lin A, Soh TG, Ooi M, Yap ES, Donato LKS, Halim NAA, Mah J, Lim K, Poon LM, Tan B, Yelly, Lim HL, Koh LP, Tai BC, Chen Z, Chng WJ, Gopalakrishnan SK, Tan LK. de Mel S, et al. Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):225-232. doi: 10.1016/j.hemonc.2018.04.001. Epub 2018 Apr 23. Hematol Oncol Stem Cell Ther. 2018. PMID: 29705566 Free article. Clinical Trial.
Potential Clinical Application of Genomics in Multiple Myeloma.
Soekojo CY, de Mel S, Ooi M, Yan B, Chng WJ. Soekojo CY, et al. Among authors: de mel s. Int J Mol Sci. 2018 Jun 10;19(6):1721. doi: 10.3390/ijms19061721. Int J Mol Sci. 2018. PMID: 29890777 Free PMC article. Review.
88 results